Why Fatigue Happens During Treatment
The compounds used in peptide and GLP-1 therapies affect your body in multiple ways simultaneously. Caloric intake typically drops because these medications suppress appetite, and that creates an energy deficit even as your metabolism starts running differently. Your system is burning fuel at a changed rate while receiving fewer calories, so low energy follows.
Hormonal shifts also play a direct role. GLP-1 agonists interact with hormones that regulate hunger, satiety, and blood sugar, and some of those same pathways influence sleep quality and your internal clock. You may notice it takes longer to fall asleep or that you wake up feeling less rested even if you slept the same number of hours.
There is also a temporary inflammatory response as your immune system registers the compound and begins adapting. This is usually mild and subsides within the first few weeks. The combination of metabolic change, hormonal adjustment, and a brief inflammatory phase adds up to a body that is working harder than usual to maintain equilibrium.
If you are logging symptoms and dose data in PeptPro during this period, you will see the fatigue show up right around when you started or increased your dose. Start tracking your symptoms here so you have that timeline clear from day one.